Imagenetix, Inc. (IAGX)
Imagenetix, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $5,685. On trailing twelve-month figures it carries a trailing P/E of -0.25, a net margin of -2.6%. Its beta of 0.66 implies it has historically moved less than the broad market.
Established in 1996 and headquartered in San Diego, California, Imagenetix, Inc. focuses on the creation, manufacturing, and distribution of distinctive, natural-ingredient nutritional supplements, as well as non-prescription topical creams and skincare solutions. Its flagship product, Celadrin, is a specialized formulation aimed at promoting joint well-being. The company also extends its business by licensing its proprietary technologies to third parties. Imagenetix reaches its customer base through a wide range of marketing avenues, encompassing direct and large-scale marketing enterprises, health and nutritional periodicals, medical and wellness professionals, and direct-response campaigns across radio and television.
Imagenetix, Inc. is most often compared with the following Healthcare names: